絞り込み

16535

広告

Interference of Therapeutic Monoclonal Antibodies With Routine Serum Protein Electrophoresis and Immunofixation in Patients With Myeloma: Frequency and Duration of Detection of Daratumumab and Elotuzumab.

著者 Tang F , Malek E , Math S , Schmotzer CL , Beck RC
Am J Clin Pathol.2018 Jun 13 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (70view , 0users)

Full Text Sources

We investigated the frequency and pattern of detection of therapeutic monoclonal antibodies (t-mAbs) daratumumab and elotuzumab by routine serum protein electrophoresis (SPE) and immunofixation (IF) in treated patients with myeloma.
PMID: 29901687 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード